BNET Industries

Market Cap:$140.6B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Monsanto To Acquire Pfizer's Chesterfield Village Research Center - Quick Facts
-
Monsanto To Acquire Pfizer's Chesterfield Village Research Center For $435 Mln. - Update
-
Pfizer slashing 600 jobs from its St. Louis area work force
-
UPDATE: Abbott Labs: US Justice Department Probing Depakote
-
Trubion loses $6.2 million in Q3
-
Pfizer extends Ligand research collaboration
-
Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor
-
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment...
-
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 4, 2009 : FLML, XING, AFFY and MOCO
-
Pfizer unveils its new Poultry Health division
-
Pfizer reportedly considers buying Protalix
-
Pfizer, GSK launch HIV drug company
-
Pfizer eyes deal with Israel's Protalix-newspaper
-
Report: Pfizer may make a bid for Protalix
-
Wockhardt says no plans to divest biotech biz
-
Pfizer Is Ordered to Pay $850,000 to Brigham Young U. for Delaying Patent Litigation
-
Pfizer leaders get $2.2 million in bonuses
-
AstraZeneca Settles Seroquel Probe
-
Pfizer Slashes Research, Staff after Wyeth Deal
-
Pfizer sues Unilab over Lipitor drug
News & Analysis
Filter by
license agreement and pfizer inc. - All News and Analysis
Helsinn and Pfizer Laboratories (Pty) Ltd Sign a License Agreement for the Marketing of Aloxi(R) in South Africa.
LUGANO, Switzerland and JOHANNESBURG, South Africa, March 10 /PRNewswire/ -- Helsinn Healthcare SA, and Pfizer Laboratories Pty Ltd, announce the signing of an agreement granting Pfizer in South Africa, the exclusive license and distribution ri LUGANO, Switzerland and JOHANNESBURG, South Africa, March...
Incyte to Host Conference Call Today to Discuss Collaborative Research and License Agreement with Pfizer for the Development and Commercialization of CCR2 Antagonists; Conference Call is Scheduled to Begin at 8:30 a.m. ET Today
WILMINGTON, Del. -- Incyte Corporation (Nasdaq:INCY) announced that it will host a conference call at 8:30 am ET today to discuss its collaborative research and license agreement with Pfizer for the development and commercialization of CCR2 antagonists. A copy of the press release, also released today, can be accessed at...
Pfizer and Incyte Enter Collaborative Research and License Agreement for the Development and Commercialization of CCR2 Antagonists
NEW YORK & WILMINGTON, Del. -- Incyte Corporation (NASDAQ:INCY):
Pfizer Inc. (Active Pharmaceutical Ingredient Watch).(seeks to terminate license agreement with Novo Nordisk )(Brief Article)
NOVO NORDISK A/S reports that Pfizer Inc. has attempted to terminate the license agreement under which Pfizer markets Novo Nordisk's portfolio of hormone replacement therapy products, Activella and Vagifem, in the US. In 2002, Novo Nordisk gained a NOVO NORDISK A/S reports that Pfizer...
Inhale Therapeutic Systems and Pfizer Inc Enter Into Pulmonary Insulin Product Development and License Agreement
PALO ALTO, Calif.--HealthWire--Jan. 19, 1995--Inhale Therapeutic Systems (Nasdaq:INHL) announced today that it has signed an agreement with Pfizer Inc (NYSE:PFE) to collaborate on the development of insulin products using Inhale's non-invasive pulmonary drug delivery system for macromolecules.
- 1
Industry Transcripts by Seeking Alpha
-
Salix Pharmaceuticals Ltd Q3 2009 Earnings Call Transcript
on Nov 09, 2009about SLXP
-
ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call
on Nov 09, 2009about ACAD
-
XOMA Ltd. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about XOMA
-
Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about HALO
-
Momenta Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about MNTA
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Best Selling Drugs Will Soon be Biologics, But Not Owned by Biotechs 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
